. 2014 Feb 21;77(3):498–508. doi: 10.1111/bcp.12218

Table 3A.

Evolution of vinflunine dose schedule during the study in patients in group 1

Evolution of vinflunine dose schedule during study Group 1 starting dose at cycle 1 = 280 mg m⁻²	n	%
Decrease to 210 mg m⁻² at cycle 2 – up to cycle 3	1	7.7
Decrease to 250 mg m⁻² at cycle 2 – up to cycle 2	2	15.4
Decrease to 250 mg m⁻² at cycle 2 – up to cycle 4	1	7.7
Increase to 320 mg m⁻² at cycle 2 – up to cycle 2	3	23.1
Increase to 320 mg m⁻² at cycle 2 – up to cycle 3	1	7.7
Increase to 320 mg m⁻² at cycle 2 – up to cycle 6	1	7.7
Increase to 320 mg m⁻² at cycle 2, decrease to 280 mg m⁻² at cycle 3 – up to cycle 4	1	7.7
Increase to 320 mg m⁻² at cycle 2, decrease to 280 mg m⁻² at cycle 3 – up to cycle 7	1	7.7
Not treated after cycle 1	2	15.4
Number of patients	13	100.0